Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase InhibitorsSílvia Marcé, Fuensanta Millá, Marta Cabezón et al.|Blood|2011Cited by 0